WaelS.SaberMDMS

PubMed

• 297 citations
  Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
  Sally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He
  Biology of Blood and Marrow Transplantation. 2015-02-01
• 172 citations
  Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.
  Anita D'Souza, Caitrin Fretham, Stephanie J Lee, Mukta Arora, Janet Brunner
  Biology of Blood and Marrow Transplantation. 2020-08-01
• 9 citations
  Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study
  Ran Reshef, Wael Saber, Javier Bolaños-Meade, George Chen, Yi Bin Chen
  Journal of Clinical Oncology. 2021-01-28

Abstracts/Posters

• Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young ...
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Pediatric Intensive Care Resource Utilization Following Hematopoietic Cell Transplantation in Children with Acute Leukemia
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Epigenomic Signatures in Myelodysplastic Syndrome Patients As Predictors of Donor Compatibility and Transplant Outcome
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Making Progress in Graft-Versus-Host Disease Prophylaxis and Microbiome Analysis in the Blood and Marrow Transplant Clinical Trials Network: Progress III (1703)/MI-Imm...
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Impact of Depth of Pretransplant Clinical Response on Outcomes of Acute Myeloid Leukemia Patients in First Complete Remission (AML-CR1) Who Undergo Allogeneic Hematopo...
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients
  Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018